Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Bullboard Posts
Comment by wwmeincon Sep 01, 2020 3:16pm
197 Views
Post# 31488077

RE:RE:RE:RE:Health Canada

RE:RE:RE:RE:Health CanadaSo lets read that nr again nrv...as you have made a statement that the company/mgmt is not making in public.

"Under this agreement, Therma will provide financing for the project in phases as certain developmental milestones are achieved, Therma will commit up to $300,000 for phase 1 which will focus on the identification of anti-COVID-19 polypeptides to be utilized in the test prototype development stage. Therma and Orpheus expect phase 1 to take approximately 45 days to complete. Therma and Orpheus have identified several third party providers to assist with the phase 1 development path."

"Therma and Orpheus are now in Phase 1 of the Co-Development agreement "

"The Company and Orpheus are well underway with Phase I activities and expect to report back to shareholders in the near future."

"
During phase 2, Therma's and Orpheus' partnership with various clinical institutions will focus on clinical validation of the test prototype in up to 250 clinical samples. After phase 2,..."


So nrv...are you trying to mislead the public here?  The Co. has clearly stated they are in a Ph I...which Rob has stated is expected to take them 45 days...Thanks. glta

***You have the freedom to correct your mis-leading post NRV....




nrv090909 wrote: Phease 1 is complete, we are in Phase 2, ppl read the earlier NR


Bullboard Posts